Qualitative and quantitative determination of anaprazole and its major metabolites in human plasma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Qualitative and quantitative determination of anaprazole and its major metabolites in human plasma

Published:2020-05 Issue: Volume:183 Page:113146
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Tang Chongzhuang,Li Liang,Ma Xifeng,Wang Jin,Chen Bo,Dai Xiaojian,Zhang Yifan,Chen Xiaoyan

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference20 articles.

1. Revealing the mechanistic pathway of acid activation of proton pump inhibitors to inhibit the gastric proton pump: a DFT study;Jana;J. Phys. Chem. B,2016

2. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the american gastroenterological association;Freedberg;Gastroenterology,2017

3. Repositioning of proton pump inhibitors in cancer therapy;Lu;Cancer Chemother. Pharmacol.,2017

4. Review article: relationship between the metabolism and efficacy of proton pump inhibitors - focus on rabeprazole;Horn;Aliment Pharm Therap,2004

5. Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem;Padol;Int J Clin Pharmacol Ther,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Absorption, Metabolism, and Excretion of [¹⁴C]‐Labeled Anaprazole: A New Proton Pump Inhibitor, After a Single Oral Administration in Healthy Chinese Male Subjects;Clinical Pharmacology in Drug Development;2024-08-05

2. Integrated models of population pharmacokinetics and exposure response to optimize dosage regimen for anaprazole sodium in duodenal ulcer;European Journal of Pharmaceutical Sciences;2024-07

3. Safety, Tolerability, and Pharmacokinetics of Anaprazole, a Novel Proton Pump Inhibitor, in Healthy Chinese Subjects;Clinical Pharmacology in Drug Development;2024-04-17

4. Physiologically based pharmacokinetic modeling to assess the drug-drug interactions of anaprazole with clarithromycin and amoxicillin in patients undergoing eradication therapy of H. pylori infection;European Journal of Pharmaceutical Sciences;2023-10

5. Combined contributions of cytochrome P450s (CYPs) and non-enzymatic metabolism in the in vitro biotransformation of anaprazole, a novel proton pump inhibitor;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-02-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3